BAY-218
BAY-218 (AHR antagonist 1) is an aryl hydrocarbon receptor (AHR) antagonist. BAY-218 has AHR inhibitory activity with an IC50 of 39.9 nM in in U87 glioblastoma cells. BAY-218 can be used for the research of cancer or conditions with dysregulated immune responses[1].
Product Specifications
CAS Number
[2162982-11-6]
Product Name Alternative
AHR antagonist 1
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Aryl Hydrocarbon Receptor
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/bay-218.html
Purity
99.78
Solubility
DMSO : ≥ 250 mg/mL
Smiles
O=C(C1=CC(C2=CC=C(Cl)C=C2)=NN(C3=CC=CC(F)=C3)C1=O)N[C@@H](C)CO
Molecular Formula
C20H17ClFN3O3
Molecular Weight
401.82
Precautions
H315, H319, H335
References & Citations
[1]Norbert Schmees, et al. 3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides. WO2017202816A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Phospho-PAK1/2/3 (Ser144/Ser141/Ser154) Recombinant Antibody, APC-Cy5.5 Conjugated
Lentiviral human KLF3 shRNA (UAS) - Lentiviral human KLF3 shRNA (UAS, iRFP) (25)
